ICD implantation with and without combined myocardial revascularisation -: Incidence of ICD therapy and late survival

Background: Our aim was to evaluate the occurrence of implanted cardioverter-defibrillator (ICD) shock and antitachycardia pacing (ATP), the effect of ICD therapies on mortality and the impact of revascularisation strategies on arrhythmic events. Patients and Methods: We investigated 130 CAD patients undergoing ICD implantation between 1984 and 1999. Results: Freedom of shock was 66 +/- 7%, 48 +/- 9% and 48 9% after 1, 3 and 5 years in patients with revascularisation and 62 +/- 8%, 38 +/- 10%, respectively; p = n. s. There were no significant differences in cumulative survival between patients with and without revascularisation; p = n. s. Conclusions: CAD patients with VT/VF and with implanted ICD have, despite successful revascularisation, the same rate of device therapy and mortality as patients without an indication of revascularisation. This implies that patients with chronic ischemic heart disease and ventricular tachyarrhythmias continue to be at risk of sudden death after CABG/PTCA; evaluation for ICD implantation is warranted.